DJIA 17,827.75 12.81 0.07%
NASDAQ 4,787.32 29.07 0.61%
S&P 500 2,072.83 5.80 0.28%
market minute promo

58.86 0.34 (0.58%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMY $58.86 0.58%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $58.69
Previous Close $58.52
Daily Range $58.36 - $58.90
52-Week Range $46.30 - $59.50
Market Cap $97.6B
P/E Ratio 36.12
Dividend (Yield) $1.44 (2.5%)
Ex-Dividend Date
Dividend Pay Date
10/01/14
11/03/14
Volume 3,746,655
Average Daily Volume 7,742,388
Current FY EPS $1.79

Sector

Healthcare

Industry

Drugs

Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website: http://www.bms.com/

News & Commentary

5 Things Pfizer, Inc.'s Management Wants You to Know

Pfizer's third-quarter earnings report looked rather tame unless you dug into its quarterly conference call. Here are the five key things Pfizer's management wants you to know about where the company is headed next.

Five Prime Therapeutics Up on Deal with Bristol-Myers - Analyst Blog

Novartis' Multiple Myeloma Drug FDA Action Date Delayed - Analyst Blog

UPDATE 1-FDA declines to approve Bristol-Myers hepatitis drug

FDA declines to approve Bristol-Myers hepatitis drug

Another Cancer Drug Deal, It’s Bristol-Myers Squibb This Time

Celgene's PDE4 Inhibitor Otezla Gets Positive CHMP Opinion - Analyst Blog

Novo Nordisk's Victoza Recommended for Label Expansion - Analyst Blog

A Buy Recommendation From Absolute Valuation Model to Bristol-Myers Squibb

Why These Big Pharma Stocks Could Plunge Next Year

We asked three of our top healthcare analysts which big pharma stocks could face tough times in 2015. Here is what they had to say.

See More BMY News...

BMY's Top Competitors

BMY $58.86 (0.58%)
Current stock: BMY
PFE $31.10 (2.07%)
Current stock: PFE
RHHBY $37.41 (0.54%)
Current stock: RHHBY
NVS $95.56 (0.55%)
Current stock: NVS